Behavior of self-propelled acetone droplets in a Leidenfrost state on liquid substrates

It is demonstrated that non-coalescent droplets of acetone can be formed on liquid substrates. The fluid flows around and in an acetone droplet hovering on water are recorded to shed light on the mechanisms which might lead to non-coalescence. For sufficiently low impact velocities, droplets undergo a damped oscillation on the surface of the liquid substrate but at higher velocities clean bounce-off occurs. Comparisons of experimentally observed static configurations of floating droplets to predictions from a theoretical model for a small non-wetting rigid sphere resting on a liquid substrate are made and a tentative strategy for determining the thickness of the vapor layer under a small droplet on a liquid is proposed. This strategy is based on the notion of effective surface tension. The droplets show self-propulsion in straight line trajectories in a manner which can be ascribed to a Marangoni effect. Surprisingly, self-propelled droplets can become immersed beneath the undisturbed water surface. This phenomenon is reasoned to be drag-inducing and might provide a basis for refining observations in previous work

Phosphoinositide-dependent regulation of VAN3 ARF-GAP localization and activity essential for vascular tissue continuity in plants

ACAP-type ARF GTPase activating proteins (ARF-GAPs) regulate multiple cellular processes, including endocytosis, secretion, phagocytosis, cell adhesion and cell migration. However, the regulation of ACAP functions by other cellular proteins is poorly understood. We have reported previously that a plant ACAP, VAN3, plays a pivotal role in plant venation continuity. Here, we report on newly identified VAN3 regulators: the CVP2 (cotyledon vascular pattern 2) 5 PTase, which is considered to degrade IP3 and also to produce PtdIns(4) P from PtdIns(4,5) P-2; and a PH domain-containing protein, VAB (VAN3 binding protein). Combinational mutations of both CVP2 and its closest homologue CVL1 (CVP2 like 1) phenocopied the strong allele of van3 mutants, showing severe vascular continuity. The phenotype of double mutants between van3, cvp2 and vab suggested that VAN3, CVP2 and VAB function in vascular pattern formation in the same pathway. Localization analysis revealed that both CVP2 and VAB colocalize with VAN3 in the trans-Golgi network (TGN), supporting their functions in the same pathway. The subcellular localization of VAN3 was dependent on its PH domain, and mislocalization of VAN3 was induced in cvp2 or vab mutants. These results suggest that CVP2 and VAB cooperatively regulate the subcellular localization of VAN3 through the interaction between its PH domain and phosphoinositides and/or inositol phosphates. In addition, PtdIns(4) P, to which VAN3 binds preferentially, enhanced the ARF-GAP activity of VAN3, whereas IP3 inhibited it. These results suggest the existence of PtdIns(4) P and/or IP3-dependent subcellular targeting and regulation of VAN3 ACAP activity that governs plant vascular tissue continuity

Initial Operation Results of a 50kg-class Deep Space Exploration Micro-Spacecraft PROCYON

This paper presents the development and initial operation results of 50kg-class deep space exploration microspacecraft PROCYON (Proximate Object Close flYby with Optical Navigation), which was jointly developed by the University of Tokyo and Japan Aerospace Exploration Agency (JAXA). The primary mission of PROCYON is the world’s first demonstration of 50kg-class deep space exploration bus system which includes the demonstration of high-efficiency GaN-based SSPA (Solid State Power Amplifier) for communication and high-precision navigation by a novel method of DDOR (Delta Differential One-way Range) observation. PROCYON also has some secondary advanced missions, which are deep space flight to a Near-earth asteroid and high resolution observation of the asteroid during close and fast flyby, and the wide view scientific observation of geocorona by a Lyman alpha imager from a vantage point outside of the Earth’s geocoronal distribution. PROCYON was developed at very low cost (a few million dollars) and within very short period (about 1 year), taking advantage of the heritage from Japanese Earth-orbiting micro satellite missions. PROCYON was launched into an Earth departure trajectory together with Japanese second asteroid sample return spacecraft Hayabusa-2 on December 3, 2014, and it has achieved its primary mission and some of the secondary missions

Striosomal opioid receptors

The opioid peptide receptors consist of three major subclasses, namely, μ, δ, and κ (MOR, DOR, and KOR, respectively). They are involved in the regulation of striatal dopamine functions, and increased opioid transmissions are thought to play a compensatory role in altered functions of the basal ganglia in Parkinson's disease (PD). In this study, we used an immunohistochemistry with tyramide signal amplification (TSA) protocols to determine the distributional patterns of opioid receptors in the striosome-matrix systems of the rat striatum. As a most striking feature of striatal opioid anatomy, MORs are highly enriched in the striosomes and subcallosal streak. We also found that DORs are localized in a mosaic pattern in the dorsal striatum (caudate-putamen), with heightened labeling for DOR in the striosomes relative to the matrix compartment. In the 6-hydroxydopamine-lesioned rat model of PD, lesions of the nigrostriatal pathways caused a significant reduction of striatal labeling for both the MOR and DOR in the striosomes, but not in the matrix compartment. Our results suggest that the activities of the striosome and matrix compartments are differentially regulated by the opioid signals involving the MORs and DORs, and that the striosomes may be more responsive to opioid peptides (e.g., enkephalin) than the matrix compartment. Based on a model in which the striosome compartment regulates the striatal activity, we propose a potent compensatory role of striosomal opioid signaling under the conditions of the striatal dopamine depletion that occurs in PD

Central effects of botulinum toxins

Because of its unique ability to exert long-lasting synaptic transmission blockade, botulinum neurotoxin A (BoNT/A) is used to treat a wide variety of disorders involving peripheral nerve terminal hyperexcitability. However, it has been a matter of debate whether this toxin has central or peripheral sites of action.We employed a rat model in which BoNT/A1 or BoNT/A2 was unilaterally injected into the gastrocnemius muscle. On time-course measurements of compound muscle action potential (CMAP) amplitudes after injection of BoNT/A1 or BoNT/A2 at doses ranging from 1.7 to 13.6U, CMAP amplitude for the ipsilateral hind leg was markedly decreased on the first day, and this muscle flaccidity persisted up to the 14th day. Of note, both BoNT/A1 and BoNT/A2 administrations also resulted in decreased CMAP amplitudes for the contralateral leg in a dose-dependent manner ranging from 1.7 to 13.6U, and this muscle flaccidity increased until the fourth day and then slowly recovered. Immunohistochemical results revealed that BoNT/A-cleaved synaptosomal-associated protein of 25 kDa (SNAP-25) appeared in the bilateral ventral and dorsal horns 4 days after injection of BoNT/A1 (10 U) or BoNT/A2 (10 U), although there seemed to be a wider spread of BoNT/A-cleaved SNAP-25 associated with BoNT/A1 than BoNT/A2 in the contralateral spinal cord. This suggests that the catalytically active BoNT/A1 and BoNT/A2 were axonally transported via peripheral motor and sensory nerves to the spinal cord, where they spread through a transcytosis (cell-to-cell trafficking) mechanism. Our results provide evidence for the central effects of intramuscularly administered BoNT/A1 and BoNT/A2 in the spinal cord, and a new insight into the clinical effects of peripheral BoNT/A applications